EUVIMEDEUVIMED entdecken
Open Access

Cobalt Oxide/Nickel Cobalt Sulfide/Poly(1,8‐diaminonaphthalene) Electrochemical Sensor‐Based Therapeutic Monitoring of Primaquine in Urine to Combat Low Treatment Adherence in Vivax Malaria Therapy

Faith Muthoni Wangui, Darko Kwabena Adu, John Alake, Malachie Monyele Tembo iD, Rajshekhar Karpoormath iD

ChemPlusChem · 2026

DOI: 10.1002/cplu.70225 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemPlusChem, 2026. Verfasst von Faith Muthoni Wangui und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa. Hauptthemen laut MEDLINE: Primaquine, Cobalt, Electrochemical Techniques, Oxides. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: College of Health Sciences, University of KwaZulu-Natal, College of Health Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients’ compliance with primaquine treatment is low due to the long 14‐day duration of primaquine and the toxic side effects, including acute hemolytic anemia. This study aimed to develop a cobalt oxide/nickel cobalt sulfide/poly(1,8‐diaminonaphthalene) (Co 3 O 4 @NiCo 2 S 4 @poly(1,8‐DAN))‐based electrochemical sensor for monitoring primaquine in urine to combat low adherence. The Co 3 O 4 @NiCo 2 S 4 @poly(1,8‐DAN) nanocomposite was synthesized using hydrothermal and oxidative polymerization and characterized using high‐resolution transmission electron microscopy (HRTEM), energy‐dispersive X‐ray spectroscopy (EDS), scanning electron microscopy (SEM), and Fourier transform infrared spectroscopy (FTIR). Differential pulse voltammetry (DPV) and electrochemical impedance spectroscopy were used to study the electrochemical properties of the nanocomposite. A 5 μL aliquot of Co 3 O 4 @NiCo 2 S 4 @poly(1,8‐DAN) was drop‐casted onto the glassy carbon electrode, and DPV was used to evaluate the electrochemical sensor’s performance. A linear calibration response was established over primaquine’s concentration range of 10–50 µM. The study found a detection limit of 2.51 nM with a linear concentration range of 10–50 µM. Real sample analysis in urine demonstrated recovery ranges of 98.3%–101.1%. This study reports, for the first time, the synthesis of the Co 3 O 4 @NiCo 2 S 4 @poly(1,8‐DAN) ternary nanocomposite and its application for the detection of primaquine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PrimaquineCobaltElectrochemical TechniquesOxidesNickel1-NaphthylamineAntimalarialsPolymersHumansNanocomposites

Stichwörter der Autor:innen

cobalt oxidemalarianickel cobalt sensorspoly(1,8‐diaminonaphthalene)primaquine

Substanzen

PrimaquineCobaltOxidescobalt oxideNickel1-Naphthylaminecobaltous sulfideAntimalarialsPolymers

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.

ORCID-Profile: Malachie Monyele Tembo, Rajshekhar Karpoormath

Förderung

  • College of Health Sciences, University of KwaZulu-Natal
  • College of Health Sciences

Zitieren

APA

Wangui, F. M., Adu, D. K., Alake, J., Tembo, M. M., & Karpoormath, R. (2026). Cobalt Oxide/Nickel Cobalt Sulfide/Poly(1,8‐diaminonaphthalene) Electrochemical Sensor‐Based Therapeutic Monitoring of Primaquine in Urine to Combat Low Treatment Adherence in Vivax Malaria Therapy. ChemPlusChem. https://doi.org/10.1002/cplu.70225

Vancouver

Wangui FM, Adu DK, Alake J, Tembo MM, Karpoormath R. Cobalt Oxide/Nickel Cobalt Sulfide/Poly(1,8‐diaminonaphthalene) Electrochemical Sensor‐Based Therapeutic Monitoring of Primaquine in Urine to Combat Low Treatment Adherence in Vivax Malaria Therapy. ChemPlusChem. 2026. doi:10.1002/cplu.70225

BibTeX
@article{Wangui2026,
  author = {Wangui, Faith Muthoni and Adu, Darko Kwabena and Alake, John and Tembo, Malachie Monyele and Karpoormath, Rajshekhar},
  title = {Cobalt Oxide/Nickel Cobalt Sulfide/Poly(1,8‐diaminonaphthalene) Electrochemical Sensor‐Based Therapeutic Monitoring of Primaquine in Urine to Combat Low Treatment Adherence in Vivax Malaria Therapy},
  journal = {ChemPlusChem},
  year = {2026},
  doi = {10.1002/cplu.70225}
}
Kostenlos starten →